WELLINGTON MANAGEMENT GROUP LLP - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 56 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$1,100,871
+5.4%
81,971
-3.0%
0.00%
Q4 2022$1,044,807
-16.2%
84,463
-5.5%
0.00%
Q3 2022$1,247,000
-4.4%
89,412
-5.3%
0.00%
Q2 2022$1,304,000
-15.1%
94,3760.0%0.00%
Q1 2022$1,536,000
-1.3%
94,376
-1.3%
0.00%
Q4 2021$1,557,000
-95.4%
95,605
-65.0%
0.00%
-100.0%
Q4 2019$33,817,000
+2080.3%
272,893
+1067.6%
0.01%
Q3 2019$1,551,000
+10.9%
23,372
+32.9%
0.00%
Q2 2019$1,399,000
+153.0%
17,584
+255.3%
0.00%
Q1 2019$553,000
+13.3%
4,949
-14.9%
0.00%
Q2 2018$488,000
+28.8%
5,816
+263.5%
0.00%
Q3 2014$379,000
-15.8%
1,600
-15.8%
0.00%
Q2 2014$450,000
-86.4%
1,900
-81.0%
0.00%
-100.0%
Q1 2014$3,303,000
-9.1%
10,015
-87.6%
0.00%0.0%
Q2 2013$3,632,00081,0000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders